370 related articles for article (PubMed ID: 8118011)
41. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Shinoda H; Inaba M; Tsuruo T
Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
[TBL] [Abstract][Full Text] [Related]
42. Isolation and characterization of a murine P388 leukemia line resistant to thiarabine.
Waud WR; Parker WB; Gilbert KS; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2012; 31(1):14-27. PubMed ID: 22257207
[TBL] [Abstract][Full Text] [Related]
43. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
Green D; Bensely D; Schein P
Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
[TBL] [Abstract][Full Text] [Related]
44. Treatment of murine testicular leukemia.
Hoots WK; Nelson JA
Cancer Res; 1984 Jun; 44(6):2464-6. PubMed ID: 6722788
[TBL] [Abstract][Full Text] [Related]
45. Applicability of anti-neovascular therapy to drug-resistant tumor: suppression of drug-resistant P388 tumor growth with neovessel-targeted liposomal adriamycin.
Shimizu K; Asai T; Fuse C; Sadzuka Y; Sonobe T; Ogino K; Taki T; Tanaka T; Oku N
Int J Pharm; 2005 May; 296(1-2):133-41. PubMed ID: 15885465
[TBL] [Abstract][Full Text] [Related]
46. [Study for modifying activity of solvents on antitumor activity of paclitaxel].
Fujimoto S
Gan To Kagaku Ryoho; 1994 Apr; 21(5):665-70. PubMed ID: 7908793
[TBL] [Abstract][Full Text] [Related]
47. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
48. Involvement of macrophages and cytokines into rejection mechanism of the drug-resistant and immunogenic murine lymphoma P388/adria.
Kisseleva E; Becker M; Lemm M; Fichtner I
Anticancer Res; 1996; 16(4A):1971-8. PubMed ID: 8712729
[TBL] [Abstract][Full Text] [Related]
49. In vivo development and in vitro characterization of a subclone of murine P388 leukemia resistant to bis(diphenylphosphine)ethane.
Hoke GD; McCabe FL; Faucette LF; Bartus JO; Sung CM; Jensen BD; Heys JR; Rush GF; Alberts DW; Johnson RK
Mol Pharmacol; 1991 Jan; 39(1):90-7. PubMed ID: 1898982
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells.
Takenaga K; Tagawa M; Sakiyama S
Anticancer Res; 1996; 16(2):681-5. PubMed ID: 8687114
[TBL] [Abstract][Full Text] [Related]
51. [Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo].
Demidova NS; Goncharova SA; Chernova OB; Kopnin BP; Gudkov AV
Genetika; 1987 Oct; 23(10):1797-806. PubMed ID: 3692152
[TBL] [Abstract][Full Text] [Related]
52. Concepts for controlling drug-resistant tumor cells.
Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
[No Abstract] [Full Text] [Related]
53. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Ramu A; Fuks Z; Gatt S; Glaubiger D
Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
[TBL] [Abstract][Full Text] [Related]
54. In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
Ling YH; Priebe W; Yang LY; Burke TG; Pommier Y; Perez-Soler R
Cancer Res; 1993 Apr; 53(7):1583-9. PubMed ID: 8453627
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D
Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
[TBL] [Abstract][Full Text] [Related]
56. Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B1.
Valeriote F; Medoff G; Dieckman J
Cancer Res; 1979 Jun; 39(6 Pt 1):2041-5. PubMed ID: 445402
[TBL] [Abstract][Full Text] [Related]
57. Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933.
Mazzoni A; Canti G
Sel Cancer Ther; 1990; 6(4):167-76. PubMed ID: 2094936
[TBL] [Abstract][Full Text] [Related]
58. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
Potemski P; Polakowski P
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
[TBL] [Abstract][Full Text] [Related]
59. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
Frankfurt OS
J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
[TBL] [Abstract][Full Text] [Related]
60. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
